Skip to main content
Clinical Trials/KCT0008240
KCT0008240Not yet recruiting未知

ecessity and effectiveness of empirical antibiotic use in mild to moderate acute inflammatory gallbladder disease; a Multicenter double-blind, randomized, placebo-controlled trial

The Catholic University of Korea, Seoul St. Mary's Hospital0 sites370 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
370

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
19(Year) to 69(Year) (—)
Sex
All

Inclusion Criteria

  • ? Patients who are scheduled to undergo laparoscopic surgery among patients with acute cholecystitis who have no evidence of systemic infection between the ages of 19 and 70
  • ? Patients with acute cholecystitis with preserved gallbladder walls in the group of patients with acute cholecystitis (grade I by Tokyo guidelines) and moderate (grade II)
  • ? Cholecystitis with gallbladder wall thickness of more than 4mm or adhesion to surrounding organs due to gallbladder inflammation
  • ? A person who voluntarily signs a written consent form after hearing and understanding the description of this clinical trial

Exclusion Criteria

  • ? Those who are scheduled to undergo elective gallbladder surgery (chronic cholecystitis, etc.)
  • ? gallbladder disease, not inflammatory disease (GB Cancer, GB polyp)
  • ? Among the patients with acute cholecystitis, patients with grade II or III by Tokyo guidelines with unpreserved gallbladder walls
  • ? Pregnant or lactating women
  • ? A person who performs surgery simultaneously due to other organ diseases.
  • ? Those with immunosuppressive and hemorrhagic tendencies
  • ? A person who performed percutaneous cholecyst drainage (PTGBD) before alcohol
  • ? A person who is required to install a drainage tube during surgery
  • ? People who overreact to cephalosporin antibiotics.
  • ? A person who participates in another clinical trial within 3 months prior to screening
  • ? Other persons deemed unfit for participation in this clinical trial by the tester;

Investigators

Similar Trials